Genomics Inform Search

CLOSE


Genomics Inform > Volume 19(4); 2021 > Article
Kotoulas: COVID-19 pandemic: Is it the right time to develop interconnected national biomedical registries?
Biomedical data storage procedures and reuse availabilities are essential for high-quality healthcare, therapeutic protocols improvements, pharmacy vigilance, and public health surveillance. Healthcare personnel and information have recognized the continuous need for the improvement of electronic health records and interoperability among different healthcare/hospital information systems [1]. Moreover, prior research has indicated that the integration of molecular/genomic and clinical data is unquestionably necessary and valuable to fight against the majority of diseases. In biomedical research, relative literature accompanied by clinical and molecular data repositories as well as coordinated actions have already been implemented worldwide to enhance international bio-data exchange and cross-country comparison of healthcare performance [2,3]. Although national-scale electronic registries, healthcare initiatives, and data sharing approaches have been emerged to promote individual medicine, there is still much international effort to accomplish bio-data sharing and overcome sensitive patient data issues.
On the one hand, the coronavirus disease 2019 (COVID-19) outbreak has already influenced several human social activities and has changed the modern standard of life. Throughout history, humankind has faced and recorded the consequences of prior epidemics by finding solutions and adopting epidemic response policies [4,5]. Most healthcare systems and medical staff are overstretched every day worldwide. Furthermore, the selective lockdown remains the last of a series of restrictive government measures enacted to fight the spread of the virus and maintain the daily operation of health units at manageable levels as much as possible [6,7]. On the other hand, clinical studies/trials are always at the top of scientific biomedical efforts and research. Since scientists became aware of the discernible risk of new severe acute respiratory syndrome coronavirus (SARS-CoV) strains, more than 4,000 clinical studies/trials have been submitted to the Clinical Trial. Gov database. The recent announcements regarding the SARS-CoV-2 vaccine solutions and the various pharmaceutical interventions have brought hope to the world from a therapeutic and an economic standpoint [8,9]. Additionally, several digital transformation paradigms have emerged through the pandemic, globally. From a health IT perspective, the healthcare crisis has triggered computer scientists and IT companies to develop high-speed networks and software to compensate for travel restrictions and the closure of businesses and educational structures [10,11].
In 2019, we proposed a national biomedical registry framework for the enhancement of clinical research using free open-source software (FOSS). We focused on a data entry framework for the genomic and molecular information of a patient [12]. In addition, in translating multiple query results from the ClinicalTrials.gov database with mesh terms [[(‘any condition)’ AND [(‘mutation’) OR (‘SNP’) OR (‘gene’) OR (‘genetic’) OR (‘allele’)]] to a proposed eGov health policy (Fig. 1), we developed the following generic proposals: (1) “If every country develops a web-based national biomedical registry, the genomic/molecular information of a patient should be a priority in its design”, and (2) “Biomedical Informatics will play a vital role in the implementation of a national biomedical registry in every country, worldwide”. Moreover, when we searched the ClinicalTrials.gov database, we found more than 100 genomic-related COVID-19 clinical studies/trials. After reviewing the modern biomedical research, our team believes that a personal bio-molecular signature should be registered either via a custom national healthcare application or via the generic modular parts of the structured electronic healthcare record of a hospital information system. Academic and commercial streamline software including bio-molecular database structures (i.e., DNA mutations, SNPs, PCR results) and further technical details (i.e., Flat files, VCF files, binary large objects, usage of molecular biology/bioinformatics databases annotations) have been published over a decade to integrate cross-country clinical and molecular databases [13-17]. Recent advanced technology, combining NoSQL databases, molecular/genomic standard data structures, cloud architectures, reliable FOSS, and highs performance computing servers, seems promising to efficiently manage large next-generation sequencing/whole genome sequencing data and distribute via web services individuals’ bio-information [18-20].
Therefore, it is highly possible that IT management and eGov policies can create positive change in the pandemic. If the clinical researchers could rapidly find eligible patients or a cohort of healthy individuals for clinical research, based on their biomedical information and via interconnected web frameworks, then the personalized medicine and vaccine development research would be enhanced. The global healthcare IT community should focus on the implementation of a generic structured biomedical registry in every country. Without a doubt, a centralized national biomedical patient record could contribute to both solving long-term problems and research on rare diseases, as well as epidemiological studies. In the present infectious disease era, all countries must support biomedical cooperation and the development of interoperable health IT systems in parallel to other crucial data collection viewpoints. Maintaining the security of a person’s sensitive information, electronic biomedical data interchange that is used to suppress a pandemic could be supported through the development of web-based national biomedical registries [20,21]. Regardless of the COVID-19 outbreak, the next generation of integrated hospital information systems will play a key role in healthcare innovation globally [22-25]. A possible obstacle in this direction is the extra burden that may fall on healthcare staff. Especially the medical staff is burdened with the task of entering and updating patient health data. It is also a fact that medical staff needs to improve their health informatics skills to be able to efficiently exploit healthcare software [20,24,25]. Consequently, health information exchange, health IT skills, modern web services solutions, and interoperability between hospital information systems and molecular diagnostics laboratories, are parameters of the same equation for common healthcare policies.
As a registered nurse, molecular biologist, and informatician scientist, I strongly believe that healthcare personnel are destined to play a key aspect in the proposed interconnected national biomedical registries. Furthermore, clinical and laboratory processes within a hospital should be applied to electronic health records and other healthcare software documentations. In the generic digital transformation that has already come from the COVID-19 pandemic, healthcare personnel could further assist in storing the individual, clinical, and genomic profile of each patient. In this way, the objective purposes of the proposed biomedical registries, the clinical research, and the levels of biomedical knowledge and research will be significantly promoted. Thinking to the future, I am convinced that Biomedical & Genomics Informatics will be at the forefront of the desired qualifications of health professionals, and every designed step for a new Public Health Policy by any government healthcare administration will be followed by the solutions derived from Health Informatics.

Notes

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Fig. 1.
ClinicalTrials.Gov database example query [‘any condition’ AND ‘mutation’ AND ‘completed with results’]: number of registered mutation-based clinical studies with results.
gi-21021f1.jpg

References

1. Meystre SM, Lovis C, Burkle T, Tognola G, Budrionis A, Lehmann CU. Clinical data reuse or secondary use: current status and potential future progress. Yearb Med Inform 2017;26:38–52.
crossref pmid pmc
2. Gabetta M, Limongelli I, Rizzo E, Riva A, Segagni D, Bellazzi R. BigQ: a NoSQL based framework to handle genomic variants in i2b2. BMC Bioinformatics 2015;16:415.

3. European Commission. EuroREACH: a handbook to access health care data for cross-country comparisons of efficiency and quality. Brussels: EU Publication Office, 2021. Accessed 2021 Dec 9. Available from: https://cordis.europa.eu/project/id/242099/reporting.
crossref pmid
4. Monto AS, Fukuda K. Lessons from influenza pandemics of the last 100 years. Clin Infect Dis 2020;70:951–957.
crossref pmid
5. Watkins J. Preventing a covid-19 pandemic. BMJ 2020;368:m810.
crossref pmid
6. Rimmer A. Covid-19: government must reduce social mixing after lockdown, says BMA. BMJ 2020;371:m4522.
crossref pmid pmc
7. Han E, Tan MM, Turk E, Sridhar D, Leung GM, Shibuya K, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet 2020;396:1525–1534.
crossref pmid pmc
8. Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Res 2020;288:198114.
crossref pmid
9. Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol 2020;20:615–632.
crossref pmid
10. Sarbadhikari S, Sarbadhikari SN. The global experience of digital health interventions in COVID-19 management. Indian J Public Health 2020;64(Suppl):S117–S124.
crossref pmid pmc
11. Reeves JJ, Hollandsworth HM, Torriani FJ, Taplitz R, Abeles S, Tai-Seale M, et al. Rapid response to COVID-19: health informatics support for outbreak management in an academic health system. J Am Med Inform Assoc 2020;27:853–859.
crossref
12. Kotoulas A, Lambrou G, Koutsouris DD. Design and virtual implementation of a biomedical registry framework for the enhancement of clinical trials: colorectal cancer example. BMJ Health Care Inform 2019;26:1–10.
crossref pmid pmc
13. Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med 2020;18:216.
crossref pmid pmc
14. Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev 2020;296:205–219.
crossref pmid pmc
15. Wang Z, Zheutlin A, Kao YH, Ayers K, Gross S, Kovatch P, et al. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records. BMJ Open 2020;10:e040441.
pmid pmc
16. Truong CV, Groeneveld LF, Morgenstern B, Groeneveld E. MolabIS: an integrated information system for storing and managing molecular genetics data. BMC Bioinformatics 2011;12:425.

17. HGMD. Human Gene Mutation Database. Cardiff: Cardiff University, 2020. Accessed 2021 Dec 9. Available from: http://www.hgmd.cf.ac.uk/ac/index.php.
crossref pmid pmc
18. Aniceto R, Xavier R, Guimaraes V, Hondo F, Holanda M, Walter ME, et al. Evaluating the Cassandra NoSQL Database approach for genomic data persistency. Int J Genomics 2015;2015:502795.
crossref pmid pmc
19. Schulz WL, Nelson BG, Felker DK, Durant TJ, Torres R. Evaluation of relational and NoSQL database architectures to manage genomic annotations. J Biomed Inform 2016;64:288–295.
crossref pmid
20. Brookfield C. Why healthcare workers spend more time with data entry and tech problems than with patients. Theale: Data Select Limited, 2020. Accessed 2021 Dec 9. Available from: https://www.dataselect.com/why-healthcare-workers-spend-more-time-with-data-entry-and-tech-problems-than-with-patients.

21. Lytras MD, Papadopoulou P, Sarirete A. Smart healthcare: emerging technologies, best practices, and sustainable policies. In: Innovation in Health Informatics (Lytras MD, Sarirete A, eds.). London: Academic Press, 2020. pp. 3–38.

22. Aziz HA, Alshekhabobakr HM. Health informatics tools to improve utilization of laboratory tests. Lab Med 2017;48:e30–e35.
crossref
23. Alger HM, Williams JHt, Walchok JG, Bolles M, Fonarow GC, Rutan C. Role of data registries in the time of COVID-19. Circ Cardiovasc Qual Outcomes 2020;13:e006766.
crossref pmid
24. Khalatbari-Soltani S, Cumming RC, Delpierre C, Kelly-Irving M. Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards. J Epidemiol Community Health 2020;74:620–623.
crossref pmid
25. Kruse CS, Stein A, Thomas H, Kaur H. The use of electronic health records to support population health: a systematic review of the literature. J Med Syst 2018;42:214.
crossref pmid pmc
TOOLS
Share :
Facebook Twitter Linked In Google+
METRICS Graph View
  • 0 Crossref
  • 0 Scopus
  • 1,417 View
  • 100 Download
Related articles in GNI


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
Room No. 806, 193 Mallijae-ro, Jung-gu, Seoul 04501, Korea
Tel: +82-2-558-9394    Fax: +82-2-558-9434    E-mail: kogo3@kogo.or.kr                

Copyright © 2022 by Korea Genome Organization.

Developed in M2PI

Close layer
prev next